Загрузка страницы

Keynote Presentation: Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics?

Presented By: Dustin Sulak, DO

Speaker Biography: Dustin Sulak, D.O. is a traditional osteopathic physician and expert in integrative medicine. His clinical practice in Maine focuses on treating refractory conditions in adults and children. Dr. Sulak is an internationally-renowned expert in medical cannabis, the author of the first foundational text on its clinical use, Handbook of Cannabis for Clinicians: Principles and Practice, and a co-founder of Healer.com, a medical cannabis education resource. He is a passionate educator and leader in the field of medical cannabis, and serves on the board of directors of The Society of Cannabis Clinicians.

Webinar: Keynote Presentation: Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics?

Webinar Abstract: While nearly all of the research on phytocannabinoids has focussed on decarboxylation products like THC and CBD, many are surprised to learn that the cannabis plant does not directly produce these compounds. The acidic cannabinoids produced by the plant, such as THCA and CBDA, have previously been considered inactive precursors to their more well-known counterparts, but increasing evidence demonstrates that these compounds have powerful therapeutic potential. In this presentation, Dr. Sulak reviews the preclinical and clinical literature demonstrating potent physiologic effects and high bioavailability of the acidic cannabinoids. He provides practical strategies for clinicians and patients to take advantage of the power of raw cannabis.

Learning Objectives:

1. Summarize the preclinical findings on acidic cannabinoids.

2. Describe the pharmacokinetics of acidic cannabinoids compared to neutral cannabinoids.

3. Describe strategies for the clinical application of acidic cannabinoids.

Earn PACE Credits:
1. Make sure you’re a registered member of LabRoots https://www.labroots.com/webinar/keynote-presentation-acidic-cannabinoids-inactive-precursors-powerful-therapeutics
2. Watch the webinar on YouTube or on the LabRoots Website https://www.labroots.com/ms/webinar/keynote-presentation-acidic-cannabinoids-inactive-precursors-powerful-therapeutics
3. Click Here to get your PACE credits (Expiration date – March 23, 2024): https://www.labroots.com/credit/pace-credits/7141/third-party

LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc

Видео Keynote Presentation: Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics? канала Labroots
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
23 апреля 2022 г. 3:08:28
01:02:45
Другие видео канала
Towards a Comprehensive Variation Benchmark for Medically-Relevant Autosomal GenesTowards a Comprehensive Variation Benchmark for Medically-Relevant Autosomal GenesSingle-Molecule Proteomics using Protein Identification by Short-epitope MappingSingle-Molecule Proteomics using Protein Identification by Short-epitope MappingFundamentals of Hematoxylin and Eosin StainingFundamentals of Hematoxylin and Eosin StainingAccelerating Microscopy Image Analysis with AIAccelerating Microscopy Image Analysis with AILessons From The Laboratory: Optimizing Your Tissue ProcessingLessons From The Laboratory: Optimizing Your Tissue ProcessingTSH & Thyroid Function Tests: why their performance mattersTSH & Thyroid Function Tests: why their performance mattersMastering basic techniques for cancer cell cultureMastering basic techniques for cancer cell cultureDelivering Improved Bioprocessing Workflows: The Manufacturing Science and Technology (MSAT) ServiceDelivering Improved Bioprocessing Workflows: The Manufacturing Science and Technology (MSAT) ServiceEvaluating Monoclonal Gammopathy of Undetermiend Significance (MGUS) with Free Light Chain Assays...Evaluating Monoclonal Gammopathy of Undetermiend Significance (MGUS) with Free Light Chain Assays...Delivering Single-Molecule Proteomics at Scale using Protein Identification by Short epitope MappingDelivering Single-Molecule Proteomics at Scale using Protein Identification by Short epitope MappingNext-Generation Sequencing (NGS) Assessment of Homologous Recombination Deficiency (HRD)...Next-Generation Sequencing (NGS) Assessment of Homologous Recombination Deficiency (HRD)...A cGMP Compatible, Non-Viral CAR T Cell Manufacturing ProcessA cGMP Compatible, Non-Viral CAR T Cell Manufacturing ProcessTechnology Platforms for Monoclonal Antibody Development and ProductionTechnology Platforms for Monoclonal Antibody Development and ProductionBeyond infection prevention and control: How genome sequencing of AMR pathogens can improve...Beyond infection prevention and control: How genome sequencing of AMR pathogens can improve...Computer System Validation (CSV): Your Path to Documenting Data IntegrityComputer System Validation (CSV): Your Path to Documenting Data IntegrityMicrobial testing for the pharmaceutical industryMicrobial testing for the pharmaceutical industryAnalytical Validation of a Next Generation Sequencing Laboratory Developed TestsAnalytical Validation of a Next Generation Sequencing Laboratory Developed TestsOncomine Precision Assay on the Ion Torrent Genexus SystemOncomine Precision Assay on the Ion Torrent Genexus SystemStandardization in Cannabis Pesticide Testing: Development of an LC-MS/MS and GC-MS/MS Method to...Standardization in Cannabis Pesticide Testing: Development of an LC-MS/MS and GC-MS/MS Method to...The Use of Polysaccharide-based Chiral Stationary Phases for the Achiral and Chiral Separation...The Use of Polysaccharide-based Chiral Stationary Phases for the Achiral and Chiral Separation...
Яндекс.Метрика